Diagnostic Approach for Unexplained Dyspnea

Initial Evaluation

• The American College of Cardiology recommends obtaining a BNP or NT-proBNP level to evaluate for heart failure with preserved ejection fraction (HFpEF), followed by echocardiography if the BNP is elevated (≥100 pg/mL) 1, 2
• BNP/NT-proBNP is the single most important next test when initial cardiac and pulmonary workup is unrevealing, with a BNP <100 pg/mL having 96-99% sensitivity for ruling out heart failure 2

Diagnostic Testing

• A negative cardiac stress test does not exclude HFpEF, which is particularly common in middle-aged women and may present with normal systolic function but diastolic dysfunction 3
• Clinical evaluation alone has high specificity (96%) but low sensitivity (59%) for cardiac causes, making biomarker testing essential 3, 4
• If BNP is elevated (≥100 pg/mL), proceed to echocardiography to assess for diastolic dysfunction, valvular disease, pulmonary hypertension, or pericardial disease 2, 3
• Echocardiography should evaluate left ventricular ejection fraction, diastolic parameters, valve function, and right ventricular systolic pressure 3

Additional Testing

• If BNP is normal (<100 pg/mL), consider cardiopulmonary exercise testing (CPET) to identify exercise-induced limitations, deconditioning, exercise-induced bronchoconstriction, or exercise-induced arterial hypoxemia 1, 5
• CPET can distinguish between cardiac, pulmonary, and deconditioning causes when resting tests are normal 5
• Exercise-induced bronchoconstriction (EIB) may not be detected on resting pulmonary function tests and requires exercise challenge or bronchoprovocation testing 5
• Obesity-related dyspnea should be considered, as it causes increased oxygen cost of breathing without bronchoconstriction, particularly in women 5
• Deconditioning is a common cause of exertional dyspnea in patients with normal resting cardiac and pulmonary function 5

Referral to Specialists

• Refer to cardiology if echocardiography reveals valvular disease requiring intervention, HFpEF, or if cardiac etiology remains suspected despite negative initial testing 2, 5
• Refer to pulmonology for consideration of interstitial lung disease, pulmonary vascular disease, or if CPET suggests pulmonary limitation 1, 5

Common Pitfalls to Avoid

• Do not assume a negative stress test excludes all cardiac causes—it primarily rules out obstructive coronary disease but not HFpEF, valvular disease, or pulmonary hypertension 3
• Do not delay evaluation of unexplained dyspnea—it is associated with increased all-cause mortality and may represent early manifestations of serious disease 6

Further Evaluation

• Consider CT chest to evaluate for interstitial lung disease, pulmonary vascular abnormalities, or subtle parenchymal disease not visible on chest radiography 3, 4
• Evaluate for anemia, thyroid dysfunction, or metabolic acidosis if not already done 4

Evidence‑Based Diagnostic Strategies for Exertional Dyspnea

Pulmonary Assessment

• Pulmonary function tests—including spirometry and diffusing capacity (DLCO)—should be performed when the chest radiograph is abnormal or when clinical features raise suspicion for pulmonary disease. [7][8]

Cardiopulmonary Exercise Testing (CPET)

• When both the complete blood count and BNP level are normal, CPET is recommended to differentiate among cardiac limitation, pulmonary limitation, deconditioning, or exercise‑induced bronchoconstriction. [7][8]

• CPET results can be classified into patterns of impaired oxygen delivery (cardiovascular), impaired oxygen utilization (peripheral muscle), or ventilatory disorders, which then direct appropriate subsequent investigations. [7][8]

Assessment of Exertional Dyspnea – Evidence‑Based Key Findings

Historical Assessment

• Duration and progression (acute vs chronic) of dyspnea are essential elements in the initial evaluation. 9
• Smoking history and occupational exposures should be systematically obtained to identify potential respiratory contributors. 9
• Assessment of recent physical activity levels and deconditioning provides context for functional limitation. 9

Medication Effects

• Beta‑blocker therapy can mask cardiac limitation by blunting heart‑rate response during exertion. 10

Physical Examination Clues

• Presence of wheezing or a prolonged expiratory phase on exam suggests underlying airway disease. 11

Cardiopulmonary Exercise Testing (CPET) Interpretation

• A low peak VO₂ combined with a normal peak heart rate points toward early cardiovascular disease, pulmonary vascular disease, deconditioning, obesity, anemia, or mitochondrial myopathy. 10
• Within this pattern, a low anaerobic threshold and reduced O₂‑pulse favor cardiac pathology over simple deconditioning. 10
• Abnormal ventilation‑efficiency ratio (VE/VCO₂), increased dead‑space ventilation (VD/VT), and exercise‑induced desaturation are indicative of pulmonary vascular disease. 10
• A normal VE/MVV ratio helps exclude primary ventilatory limitation as the cause of dyspnea. 10
• A low peak VO₂ together with a low peak heart rate suggests chronotropic incompetence, beta‑blocker effect, coronary artery disease, inadequate effort, or peripheral musculoskeletal factors. 10

Cardiac Etiologies of Exertional Dyspnea

• Coronary artery disease may manifest solely as exertional dyspnea without angina. 10
• Valvular heart disease (mitral or aortic stenosis/regurgitation) should be considered in patients with unexplained dyspnea. 10
• Pulmonary hypertension is a recognized cardiac cause of exercise limitation. 10
• Cardiac dysrhythmias, including supraventricular tachycardia, can present with exertional dyspnea. 11
• Hypertrophic cardiomyopathy is another cardiac condition associated with dyspnea on exertion. 11

Non‑Cardiac Contributors

• Gastroesophageal reflux disease can produce exercise‑induced bronchoconstriction‑like symptoms, mimicking asthma. 11
• Mitochondrial myopathy may present with a hyperdynamic ventilatory pattern and reduced exercise capacity. 10

Evidence‑Based Evaluation of Exertional Dyspnea Unresponsive to Albuterol

Clinical Indicators Suggesting Non‑Bronchoconstrictive Causes

• Lack of response to albuterol strongly indicates that the dyspnea is not due to reversible bronchoconstriction such as asthma or exercise‑induced bronchoconstriction. [12][13]
• The sensation of “chest tightness” is relatively specific for bronchoconstriction, whereas “air hunger” or unsatisfied inspiration during exertion points toward cardiac or restrictive pulmonary etiologies. 12

Pulmonary Function Testing

• Spirometry with diffusing capacity (DLCO) can identify chronic obstructive pulmonary disease (COPD) by demonstrating an obstructive pattern (reduced FEV₁/FVC). 12

Role of Cardiopulmonary Exercise Testing (CPET)

• CPET is the definitive test to distinguish among cardiac limitation, pulmonary limitation, deconditioning, and exercise‑induced bronchoconstriction in patients with unexplained exertional dyspnea. [14][13]
• An abnormal ventilatory efficiency slope (VE/VCO₂) together with increased dead‑space ventilation and exercise‑induced desaturation on CPET indicates pulmonary vascular disease. 14
• A normal VE/MVV ratio on CPET effectively excludes a primary ventilatory limitation. 14

Non‑Cardiac Contributing Factors

• Obesity‑related dyspnea raises the oxygen cost of breathing without causing bronchoconstriction and is especially common in women. 13
• Deconditioning is a frequent cause of exertional dyspnea; it presents with normal resting cardiac and pulmonary assessments but reduced exercise capacity on CPET. 13
• Gastroesophageal reflux disease can mimic exercise‑induced bronchoconstriction, leading to misinterpretation of symptoms. 13
• Exercise‑induced bronchoconstriction may not be detected on resting spirometry and therefore requires targeted testing such as CPET or bronchoprovocation. 13